Emerging Epilepsy Tool Early-stage R&D software aimed at aiding neurologists in diagnosing epilepsy syndromes at the point-of-care, presenting a potential upsell for clinics seeking decision-support tools and diagnostic accuracy.

Clinical Partnerships University-based internship program and collaboration potential with academic medical centers could open co-development, pilot studies, and proof-of-concept engagements to validate the platform and generate case studies.

Recognition & Validation Silver Stevie awards and notable funding in 2017–2018 signal external credibility; leverage awards and grant history to approach hospitals and health systems with risk mitigation and credibility assurances.

Growth Signals Reported revenue in the multi-million range and recent financing, despite a small team, indicate scalability opportunities; target mid to large hospitals seeking scalable screening tools to reduce misdiagnosis.

Adjacent Markets Technology stack and patient portal expansion suggest potential for integration with hospital IT ecosystems, EHR interoperability, and patient engagement workflows to broaden deployment in neurology and related care pathways.